[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f361ei465eva83":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"medical_code":11,"short_description":12,"alternate_name":11,"disambiguating_description":11,"citations":13,"drugs":25,"specialties":30,"cover":11},869,"b3jnqwwysi1vqj5f27nsuw48","angiotensin-converting-enzyme-inhibitor","Angiotensin Converting Enzyme Inhibitor",null,"Any substance that inhibits angiotensin-converting enzyme (ACE), an enzyme that catalyzes the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in a reduction in angiotensin II and angiotensin II-induced aldosterone secretion, causing vasodilation and natriuresis.",[14,20],{"source":15,"licence":16,"source_url":17,"harvested_by":18,"retrieved_at":19},"RxClass (NLM)","US public domain","https:\u002F\u002Frxnav.nlm.nih.gov\u002FREST\u002Frxclass\u002Fclass\u002FbyId.json?classId=N0000175562","load-reference-corpus.cjs","2026-09-13",{"source":21,"licence":22,"source_url":23,"harvested_by":18,"retrieved_at":24},"NCI Thesaurus (via NCI Metathesaurus C0003015)","NCI Thesaurus. NCI's own archived Terms of Use, still served at evs.nci.nih.gov, state: \"Permission is hereby granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the NCI THESAURUS(TM) ontology, NCI THESAURUS(TM) Users' Guide, and the NCI THESAURUS(TM) database for any commercial or non-commercial purpose\". The OBO Foundry registry records the current NCIt licence as CC BY 4.0. NCI's live licence URL https:\u002F\u002Fevs.nci.nih.gov\u002Flicense redirected to the EVS home page when checked 2026-09-16, so no first-party CURRENT licence text could be captured.","https:\u002F\u002Fapi-evsrest.nci.nih.gov\u002Fapi\u002Fv1\u002Fconcept\u002Fncit\u002FC247?include=full","2026-09-16",[26],{"id":27,"documentId":28,"slug":29,"name":29,"active_ingredient":11,"dosage_form":11,"administration_route":11},1638,"w1ay2yaf3lvcogq7uny5eie6","benazepril",[]]